Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins
- 1 December 2011
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 301 (6) , C1316-C1324
Abstract
Myostatin is a negative regulator of skeletal muscle growth and in fact acts as a potent inducer of “cachectic-like” muscle wasting in mice. The mechanism of action of myostatin in promoting muscle wasting has been predominantly studied in murine models. Despite numerous reports linking elevated levels of myostatin to human skeletal muscle wasting conditions, little is currently known about the signaling mechanism(s) through which myostatin promotes human skeletal muscle wasting. Therefore, in this present study we describe in further detail the mechanisms behind myostatin regulation of human skeletal muscle wasting using an in vitro human primary myotube atrophy model. Treatment of human myotube populations with myostatin promoted dramatic myotubular atrophy. Mechanistically, myostatin-induced myotube atrophy resulted in reduced p-AKT concomitant with the accumulation of active dephosphorylated Forkhead Box-O (FOXO1) and FOXO3. We further show that addition of myostatin results in enhanced activation of atrogin-1 and muscle-specific RING finger protein 1 (MURF1) and reduced expression of both myosin light chain (MYL) and myosin heavy chain (MYH). In addition, we found that myostatin-induced loss of MYL and MYH proteins is dependent on the activity of the proteasome and mediated via SMAD3-dependent regulation of FOXO1 and atrogin-1. Therefore, these data suggest that the mechanism through which myostatin promotes muscle wasting is very well conserved between species, and that myostatin-induced human myotube atrophy is mediated through inhibition of insulin-like growth factor (IGF)/phosphoinositide 3-kinase (PI3-K)/AKT signaling and enhanced activation of the ubiquitin-proteasome pathway and elevated protein degradation.Keywords
This publication has 38 references indexed in Scilit:
- Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoidsThe Journal of Physiology, 2011
- Elevated Myostatin Levels in Patients with Liver DiseaseAnesthesia & Analgesia, 2010
- Peroxisome Proliferator-activated Receptor γ Coactivator 1α or 1β Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse AtrophyJournal of Biological Chemistry, 2010
- Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal MuscleEndocrinology, 2008
- Replicative aging down‐regulates the myogenic regulatory factors in human myoblastsBiology of the Cell, 2008
- The E3 Ligase MuRF1 Degrades Myosin Heavy Chain Protein in Dexamethasone-Treated Skeletal MuscleCell Metabolism, 2007
- Myostatin Gene Deletion Prevents Glucocorticoid-Induced Muscle AtrophyEndocrinology, 2007
- A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheepNature Genetics, 2006
- Defective satellite cells in congenital myotonic dystrophyHuman Molecular Genetics, 2001
- The role of increased proteolysis in the atrophy and arrest of proliferation in serum‐deprived fibroblastsJournal of Cellular Physiology, 1984